Conventional-dose bicalutamide as the second-line hormonal therapy for androgen independent prostate cancer (report of 44 cases)
SUN Zhong-quan;QIAN Wei-qing;SHENG Lu;WANG Dong-ya;ZHANG Hao-jie;ZHANG Zheng-wang△
Fudan University Journal of Medical Sciences ›› 2011, Vol. 38 ›› Issue (02) : 117-120.
Conventional-dose bicalutamide as the second-line hormonal therapy for androgen independent prostate cancer (report of 44 cases)
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |